Flaxseed extract reduces tissue accumulation and enhances urinary excretion of chondroitin sulphate in the rat: a possible new path in substrate reduction therapy for mucopolysaccharidosis

Context Chondroitin 6 sulphate (C6S) is a glycosaminoglycan (GAG) whose accumulation is notable in mucopolysaccharidosis type IVA and VII. Flaxseed, Linum usitatissimum L. (Linaceae) (FS), is reported to have comparable properties to those of soybean, a source of genistein, a potential new treatment...

Full description

Saved in:
Bibliographic Details
Main Authors: Sabir Es-said (Author), Karima Lafhal (Author), Abdelaati Elkhiat (Author), Miloud Hammoud (Author), Noureddine Regbaoui (Author), Aicha Ezoubeiri (Author), Rachida Makbal (Author), Safia Sbyea (Author), Omar Elhiba (Author), Souad Sellami (Author), Hanane Rais (Author), Abdallah Karim (Author), Halima Gamrani (Author), Noureddine Rada (Author), Mohammed Bouskraoui (Author), Naima Fdil (Author)
Format: Book
Published: Taylor & Francis Group, 2022-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d89ecca18c87430a9cffffb35c0b7c90
042 |a dc 
100 1 0 |a Sabir Es-said  |e author 
700 1 0 |a Karima Lafhal  |e author 
700 1 0 |a Abdelaati Elkhiat  |e author 
700 1 0 |a Miloud Hammoud  |e author 
700 1 0 |a Noureddine Regbaoui  |e author 
700 1 0 |a Aicha Ezoubeiri  |e author 
700 1 0 |a Rachida Makbal  |e author 
700 1 0 |a Safia Sbyea  |e author 
700 1 0 |a Omar Elhiba  |e author 
700 1 0 |a Souad Sellami  |e author 
700 1 0 |a Hanane Rais  |e author 
700 1 0 |a Abdallah Karim  |e author 
700 1 0 |a Halima Gamrani  |e author 
700 1 0 |a Noureddine Rada  |e author 
700 1 0 |a Mohammed Bouskraoui  |e author 
700 1 0 |a Naima Fdil  |e author 
245 0 0 |a Flaxseed extract reduces tissue accumulation and enhances urinary excretion of chondroitin sulphate in the rat: a possible new path in substrate reduction therapy for mucopolysaccharidosis 
260 |b Taylor & Francis Group,   |c 2022-12-01T00:00:00Z. 
500 |a 10.1080/13880209.2022.2068618 
500 |a 1744-5116 
500 |a 1388-0209 
520 |a Context Chondroitin 6 sulphate (C6S) is a glycosaminoglycan (GAG) whose accumulation is notable in mucopolysaccharidosis type IVA and VII. Flaxseed, Linum usitatissimum L. (Linaceae) (FS), is reported to have comparable properties to those of soybean, a source of genistein, a potential new treatment for MPSs.Objective We assess the effect of total ethanol flaxseed extract (EFSE) in an animal model of C6S accumulation.Materials and methods The study was performed in adult male Wistar rats (n = 24) for 15 successive days. The animals were divided into four groups: (1) control injected with physiological saline buffer, (2) intoxicated rats injected intraperitoneally with C6S, (3) intoxicated with C6S and treated with EFSE, and (4) treated with EFSE. All groups were subjected to histopathological and biochemical studies. The antioxidant and phytochemical properties of EFSE were examined.Results Dry EFSE contains total phenols (6.28 mg EAG/g), condensed tannins (2.98 mg ECAT/g) and flavonoids (0.44 mg ECAT/g) with high antioxidant potential [RPE (IC50 = 8.37 ± 0.176), DPPH (IC50 = 12.79 ± 0.273)]. The LD50 is higher than 5000 mg/kg. The histopathological examination showed an accumulation of C6S in the C6S intoxicated group, which disappeared in the C6S-EFSE treated group. GAGs assays showed an increased excretion in the C6S intoxicated group and increased excretion of 14% in the C6S-EFSE group compared to the C6S group.Discussion and conclusions EFSE showed significant potential for chelation. Its use for the treatment of GAG accumulation could be suggested and generalized to a larger study population. 
546 |a EN 
690 |a Antioxidant activity 
690 |a chondroitin 6-sulphate 
690 |a chelating effect 
690 |a genistein 
690 |a quercetin 
690 |a lignans 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Pharmaceutical Biology, Vol 60, Iss 1, Pp 879-888 (2022) 
787 0 |n https://www.tandfonline.com/doi/10.1080/13880209.2022.2068618 
787 0 |n https://doaj.org/toc/1388-0209 
787 0 |n https://doaj.org/toc/1744-5116 
856 4 1 |u https://doaj.org/article/d89ecca18c87430a9cffffb35c0b7c90  |z Connect to this object online.